Targeting eosinophils: severe asthma and beyond
This review summarizes the rationale for the use of biologics in eosinophilic diseases and their mechanisms of action.
Back to homepage
Respiratory
Novel therapeutic targets for allergic airway disease in children
Keywords: allergic airway disease, allergic rhinitis, asthma, biologics, children, chronic rhinosinusitis, immunotherapy. Citation: Giallongo A, Parisi GF, Licari A, Pulvirenti G, Cuppari C, Salpietro C, Marseglia GL, Leonardia S. Novel therapeutic targets for allergic airway disease in children. Drugs in
Immunotherapy in inoperable stage III non-small cell lung cancer: a review
This article summarizes the current status and ongoing clinical trials incorporating immunotherapy into the management of inoperable stage III nonsmall cell lung cancer.
Easyhaler®: an overview of an inhaler device for day-to-day use in patients with asthma and chronic obstructive pulmonary disease
The aim of this article is to provide an overview of the scientific literature on Easyhaler, with the purpose of emphasising features that make it close to the concept of an ‘ideal’ inhaler for daily use in patients with asthma or chronic obstructive pulmonary disease.
Effectiveness and safety of mepolizumab in severe refractory eosinophilic asthma: results in clinical practice
This article analyses the effectiveness, clinical outcomes, and safety of mepolizumab in clinical practice.
